Who owns ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1?
- CUSIP Number: 02043qab3
Tip: Access positions for across all investors
Analyze quarterly positions in Alnylam Pharmaceuticals Inc Note 1.000 9/1 with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Alnylam Pharmaceuticals Inc Note 1.000 9/1 stock
Who bought or sold ALNYLAM PHARMACEUTICALS INC NOTE 1.000 9/1 this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Ing Investment Management | 140M | $206M | -18% | Dec 2025 |
|
| Alberta Investment Management Corporation | 25M | $37M | 100% | Dec 2025 |
|
| State Street Corporation | 22M | $32M | 4% | Dec 2025 |
|
| Manufacturers Life Insurance Company | 19M | $28M | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 17M | $26M | -31% | Dec 2025 |
|
| FMR | 17M | $27M | -8% | Sep 2025 |
|
| MacKay Shields | 15M | $22M | -2% | Dec 2025 |
|
| BlackRock | 13M | $19M | 30% | Dec 2025 |
|
| Lord, Abbett & Co | 7.7M | $11M | -21% | Dec 2025 |
|
| Warberg Asset Management | 5.0M | $7.4M | 67% | Dec 2025 |
|
| Amundi | 5.0M | $735M | 100% | Dec 2025 |
|
| Bnp Paribas Investment Partners | 4.8M | $7.0M | 100% | Dec 2025 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 4.5M | $6.7M | 0% | Dec 2025 |
|
| SSI Investment Management | 4.1M | $6.0M | 0% | Dec 2025 |
|
| Jpmorgan Chase & Co | 3.3M | $5.4M | 100% | Sep 2025 |
|
| Nicholas Investments Partners | 3.2M | $4.7M | 0% | Dec 2025 |
|
| State of Wisconsin Investment Board | 3.0M | $4.4M | 0% | Dec 2025 |
|
| Wellington Management Company | 2.5M | $4.1M | -86% | Sep 2025 |
|
| Invesco | 2.5M | $3.7M | 100% | Dec 2025 |
|
| Franklin Resources | 2.2M | $3.3M | -23% | Dec 2025 |
|
| Westwood Holdings | 2.1M | $2.1M | 0% | Dec 2025 |
|
| Union Bancaire Privee, UBP SA | 2.0M | $2.5M | -2% | Dec 2025 |
|
| Wells Fargo & Company | 1.4M | $2.1M | 51% | Dec 2025 |
|
| Goldman Sachs Group | 1.4M | $2.1M | 100% | Dec 2025 |
|
| AXA Investment Managers | 1.4M | $6.2M | 100% | Sep 2025 |
|
| Agf Management | 950k | $1.4M | 0% | Dec 2025 |
|
| Leucadia National Corporation | 620k | $914k | 100% | Dec 2025 |
|
| Calamos Advisors | 372k | $549k | 2% | Dec 2025 |
|
| Sei Investments | 251k | $369k | 0% | Dec 2025 |
|
| Central Pacific Bank - Trust Division | 224k | $329k | 0% | Dec 2025 |
|
| CNH Partners | 130k | $214k | 100% | Sep 2025 |
|
| Oppenheimer Asset Management | 82k | $121k | -1% | Dec 2025 |
|
| Calamos Wealth Management | 66k | $97k | 0% | Dec 2025 |
|
| Virtus ETF Advisers | 36k | $53k | -23% | Dec 2025 |
|
| Barclays | 27k | $40k | 100% | Dec 2025 |
|
| Stephens | 24k | $35k | 0% | Dec 2025 |
|
| Boussard & Gavaudan Investment Management | 21k | $31M | 60% | Dec 2025 |
|
| Balboa Wealth Partners | 15k | $22k | 0% | Dec 2025 |
|
| Stonegate Investment Group | 13k | $21k | 100% | Sep 2025 |
|
| Goss Wealth Management | 10k | $15k | 100% | Dec 2025 |
|
| Mml Investors Services | 10k | $15k | 100% | Dec 2025 |
|
| Loomis, Sayles and | 9.0k | $3.6M | 100% | Dec 2025 |
|
| CoreCap Advisors | 2.0k | $2.9k | 100% | Dec 2025 |
|
| Us Bancorp | 2.0k | $2.9k | 0% | Dec 2025 |
|
| Steward Partners Investment Advisory | 2.0k | $2.9k | 0% | Dec 2025 |
|
| Alken Asset Management | 1.0k | $1.5M | 0% | Dec 2025 |
|
| UBS Group | 670.00 | $984.967000 | 0% | Dec 2025 |
|
Who sold out of Alnylam Pharmaceuticals Inc Note 1.000 9/1?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Tenor Capital Management | Jun 2025 | 54M | $71M |
| Millennium Management | Jun 2025 | 20M | $26M |
| Zazove Associates | Jun 2025 | 18M | $23M |
| LMR Partners | Sep 2025 | 15M | $25M |
| Parallax Volatility Advisers | Sep 2025 | 11M | $18M |
| Citadel Advisors | Jun 2025 | 5.0M | $6.5M |
| Macquarie Group | Sep 2025 | 2.1M | $3.4M |
| Gabelli Funds | Sep 2025 | 2.0M | $3.3M |
| Royal Bank of Canada | Jun 2025 | 1.7M | $2.2M |
| Toronto-Dominion Bank | Jun 2025 | 1.6M | $2.1M |
| Lazard Asset Management | Sep 2025 | 980k | $16k |
| Bank of New York Mellon | Sep 2025 | 850k | $1.4M |
| Oaktree Capital Management | Jun 2025 | 750k | $976k |
| Jane Street | Sep 2025 | 550k | $912k |
| Russell Investments | Sep 2025 | 20k | $33k |
| Fifth Third Bancorp | Sep 2025 | 5.0k | $822k |